(HealthDay)—Population-based fecal immunochemical testing (FIT) screening in adults aged 50 to 69 years can reduce colorectal cancer (CRC) mortality, according to a study published online May 20 in Cancer.
Study seeks to learn from breast and cervical screening programmes to improve uptake of bowel cancer tests
Bowel cancer is the UK's second-biggest cancer killer, accounting for 10% of all cancer deaths, yet only just over half of women eligible for the screening programme in Scotland take part.
The psychological strain of being told that you may have breast cancer may be severe, even if it turns out later to be a false alarm. This is the finding of new research from the University of Copenhagen, ...